Plant Comparison
Hemp vs Vervain
A side-by-side comparison of two medicinal plants — every documented constituent, action, use, safety note and cited source, assembled automatically from the Omnia Sana database.
At a glance
Hemp and Vervain: they share 7 indicated uses (arthritis / joint pain, back pain, headache, …); 3 pharmacological actions in common.
Evidence face-off — shared uses
| Condition | Hemp | Vervain | Verdict |
|---|---|---|---|
| Arthritis / joint pain | 5/10 | 1/10 | Stronger for Hemp |
| Back pain | 5/10 | 1/10 | Stronger for Hemp |
| Headache | 5/10 | 1/10 | Stronger for Hemp |
| Inflammation (general) | 5/10 | 2/10 | Stronger for Hemp |
| Insomnia / sleeplessness | 5/10 | 2/10 | Stronger for Hemp |
| Pain (general) | 5/10 | 1/10 | Stronger for Hemp |
| Skin irritation | 5/10 | 1/10 | Stronger for Hemp |
Evidence scores (1–10) are computed from the tier of each cited source. “Comparable” means the two scores are within one point. Follow a score to its detailed sources.
Key Constituents
The characteristic bioactive compounds of the resin-bearing flowers, varying widely in ratio and concentration between cultivars; THC is psychoactive, CBD is not.
Aromatic terpenes contribute to the plant's characteristic scent and may modulate cannabinoid effects.
Hemp seed is rich in polyunsaturated fatty acids (including omega-3 and omega-6), giving the pressed seed oil its nutritional value; essentially free of psychoactive cannabinoids.
Characteristic constituents; verbenalin has a dopaminergic effect.
Antioxidant and anti-inflammatory constituents.
Supporting antioxidant and aromatic constituents.
Pharmacological Actions
Anti-inflammatory and analgesic
Nervine / anxiolytic for nervous tension and mild anxiety; supports sleep (traditional) - a crude extract showed anxiolytic, sedative and anticonvulsant activity in animal models
Nervine / anxiolytic for nervous tension and mild anxiety; supports sleep (traditional) - a crude extract showed anxiolytic, sedative and anticonvulsant activity in animal models
Digestive bitter and relief of mild mental stress
Traditional & Indicated Uses
inferred from anti-inflammatory action
inferred from anti-inflammatory action
inferred from sedative action
Nervine / anxiolytic for nervous tension and mild anxiety; supports sleep (traditional) - a crude extract showed anxiolytic, sedative and anticonvulsant activity in animal models
inferred from anti-inflammatory action
inferred from antidepressant action
inferred from anti-inflammatory action
inferred from sedative action
Nervine / anxiolytic for nervous tension and mild anxiety; supports sleep (traditional) - a crude extract showed anxiolytic, sedative and anticonvulsant activity in animal models
inferred from anti-inflammatory action
Digestive bitter and relief of mild mental stress
Safety, Cautions & Contraindications
Industrial hemp (low-THC cannabis) seed oil and seeds are generally safe as food. CBD products derived from hemp may interact with medications metabolised by cytochrome P450 liver enzymes, including common anticoagulants, antiepileptics, and immunosuppressants. THC-containing preparations impair driving and are regulated or prohibited in many jurisdictions. Not recommended during pregnancy or breastfeeding. Quality and cannabinoid content vary widely between hemp products.
Duke (2002) rates cannabis as ++ and notes clinical evidence (score 2) for its antiemetic activity, especially relevant for chemotherapy-induced nausea. Score 1 activities include analgesic, anticonvulsant, and anti-inflammatory properties. Duke highlights the legal and pharmacological complexity, noting THC as the primary psychoactive compound. Medically, synthetic cannabinoids (dronabinol, nabilone) are clinically approved for nausea and anorexia. Duke cautions that while the plant has genuine therapeutic potential, psychoactive effects, legal restrictions, and risk of dependence with regular use must be considered (Duke, 2002).
External Ids
Botanical Description
Erect annual herb with a distinctive palmately compound leaf of narrow, serrated leaflets. The plant is usually dioecious (separate male and female plants); female plants develop dense, resinous flower clusters, while male plants bear looser pollen-releasing flowers. The seed (achene) is small, hard-shelled and oil-rich.[14]
Slender, upright perennial herb with wiry, square, sparsely hairy stems and deeply lobed, toothed leaves. Tiny, pale lilac to pale purple, five-lobed flowers are borne sparsely along thin, wiry spikes at the ends of the branches, opening a few at a time.[11]
Habitat
Believed native to Central Asia; now cultivated worldwide, with industrial hemp (low-THC cultivars) grown in temperate climates for fibre, seed and cannabinoid extraction, subject to varying legal regulation by jurisdiction.[14]
Grows on dry waste ground, roadsides, field margins and disturbed soil; native to Europe, North Africa and temperate Asia and widely naturalised elsewhere.[11]
Harvesting
Flowers (and resin-bearing leaves) are harvested at peak resin/cannabinoid content, typically as the flower clusters mature in late summer to autumn; seed is harvested once mature and dried, then pressed for oil or used whole.[14]
The flowering aerial parts are cut in summer as the plant comes into flower and dried in a warm, shaded, airy place.
Traditional Uses
Cannabis/hemp has a long multi-cultural history as a fibre, food and medicinal plant, traditionally used for pain, muscle spasm, sleep and appetite, alongside industrial use of the fibre and seed. Modern cannabinoid research, particularly on THC and CBD, has substantially expanded the evidence base for pain, spasticity and specific seizure disorders.[14, 15]
Vervain has an ancient European reputation, reflected in its old names 'holy herb' and 'herb of the cross', as a calming nervine for nervous tension, anxiety and sleeplessness, and as a bitter digestive tonic; it has also traditionally been used topically and internally for aches, pains and mild inflammation.[11]
Preparations
Whole or hulled seed, or cold-pressed seed oil, used as a nutritional food source (essentially free of psychoactive cannabinoids).
Extract standardised to specific cannabinoid content (e.g. CBD), used in regulated medicinal products; regulatory status varies widely by jurisdiction and product type.
Not documented
References
Drug Class Interactions
Lookalikes Review
References & Sources
- Rock, E.M. and Parker, L.A (2021) 'Constituents of Cannabis sativa', Advances in Experimental Medicine and Biology, 1264, pp. 1-13. doi:10.1007/978-3-030-57369-0_1 Traditional / reference
https://doi.org/10.1007/978-3-030-57369-0_1 - Castillo-Arellano, J., Canseco-Alba, A., Cutler, S.J. and León, F (2023) 'The Polypharmacological Effects of Cannabidiol', Molecules, 28(7), pp. 3271. doi:10.3390/molecules28073271 Traditional / reference
https://doi.org/10.3390/molecules28073271 - Pagano, C., Navarra, G., Coppola, L., Avilia, G. et al (2022) 'Cannabinoids: Therapeutic Use in Clinical Practice', International Journal of Molecular Sciences, 23(6), pp. 3344. doi:10.3390/ijms23063344 Traditional / reference
https://doi.org/10.3390/ijms23063344 - ElSohly, M.A., Radwan, M.M., Gul, W., Chandra, S. and Galal, A (2017) 'Phytochemistry of Cannabis sativa L', Progress in the Chemistry of Organic Natural Products, 103, pp. 1-36. doi:10.1007/978-3-319-45541-9_1 Meta-analysis / review
https://doi.org/10.1007/978-3-319-45541-9_1 - Viana, M.D.B., de Aquino, P.E.A., Estadella, D., Ribeiro, D.A. and Viana, G.S.D.B (2022) 'Cannabis sativa and cannabidiol: a therapeutic strategy for the treatment of neurodegenerative diseases?', Medical Cannabis and Cannabinoids, 5(1), pp. 207-219. doi:10.1159/000527335 Meta-analysis / review
https://doi.org/10.1159/000527335 - Alves, P., Amaral, C., Teixeira, N. and Correia-da-Silva, G (2020) 'Cannabis sativa: much more beyond delta-9-tetrahydrocannabinol', Pharmacological Research, 157, pp. 104822. doi:10.1016/j.phrs.2020.104822 Meta-analysis / review
https://doi.org/10.1016/j.phrs.2020.104822 - Odieka, A.E., Obuzor, G.U., Oyedeji, O.O., Gondwe, M., Hosu, Y.S. and Oyedeji, A.O (2022) 'The medicinal natural products of Cannabis sativa Linn.: a review', Molecules, 27(5), pp. 1689. doi:10.3390/molecules27051689 Meta-analysis / review
https://doi.org/10.3390/molecules27051689 - Nuutinen, T (2018) 'Medicinal properties of terpenes found in Cannabis sativa and Humulus lupulus', European Journal of Medicinal Chemistry, 157, pp. 198-228. doi:10.1016/j.ejmech.2018.07.076 Meta-analysis / review
https://doi.org/10.1016/j.ejmech.2018.07.076 - Liktor-Busa, E., Keresztes, A., LaVigne, J., Streicher, J.M. and Largent-Milnes, T.M (2021) 'Analgesic potential of terpenes derived from Cannabis sativa', Pharmacological Reviews, 73(4), pp. 98-126. doi:10.1124/pharmrev.120.000046 Meta-analysis / review
https://doi.org/10.1124/pharmrev.120.000046 - Martinelli, G., Magnavacca, A., Fumagalli, M., Dell'Agli, M., Piazza, S. and Sangiovanni, E (2021) 'Cannabis sativa and skin health: dissecting the role of phytocannabinoids', Planta Medica, 88(7), pp. 492-506. doi:10.1055/a-1420-5780 Meta-analysis / review
https://doi.org/10.1055/a-1420-5780 - Andre, C.M., Hausman, J.F. and Guerriero, G (2016) 'Cannabis sativa: the plant of the thousand and one molecules', Frontiers in Plant Science, 7, pp. 19. doi:10.3389/fpls.2016.00019 Meta-analysis / review
https://doi.org/10.3389/fpls.2016.00019 - Bonini, S.A., Premoli, M., Tambaro, S., Kumar, A., Maccarinelli, G., Memo, M. and Mastinu, A (2018) 'Cannabis sativa: a comprehensive ethnopharmacological review of a medicinal plant with a long history', Journal of Ethnopharmacology, 227, pp. 300-315. doi:10.1016/j.jep.2018.09.004 Meta-analysis / review
https://doi.org/10.1016/j.jep.2018.09.004 - Bergamaschi, M.M., Queiroz, R.H.C., Zuardi, A.W. and Crippa, J.A.S (2011) 'Safety and side effects of cannabidiol, a Cannabis sativa constituent', Current Drug Safety, 6(4), pp. 237-249. doi:10.2174/157488611798280924 Meta-analysis / review
https://doi.org/10.2174/157488611798280924 - Cerino, P., Buonerba, C., Cannazza, G. et al (2021) 'A review of hemp as food and nutritional supplement', 6(1), pp. 19--27. doi:10.1089/can.2020.0001 Preclinical
https://doi.org/10.1089/can.2020.0001 - Devinsky, O., Cross, J.H., Laux, L. et al (2017) 'Trial of cannabidiol for drug-resistant seizures in the Dravet syndrome', 376(21), pp. 2011--2020. Randomized trial
https://scholar.google.com/scholar?q=Trial%20of%20cannabidiol%20for%20drug-resistant%20seizures%20in%20the%20Dravet%20syndrome - Royal Botanic Gardens, Kew (n.d.). Available at: https://powo.science.kew.org Traditional / reference
https://powo.science.kew.org - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition - Talwar, A., Estes, E., Aparasu, R. and Reddy, D.S (2022) 'Clinical efficacy and safety of cannabidiol for pediatric refractory epilepsy indications: A systematic review and meta-analysis', Experimental Neurology, 359, pp. 114238. doi:10.1016/j.expneurol.2022.114238 Meta-analysis / review
https://doi.org/10.1016/j.expneurol.2022.114238 - Caus, M.N., Lupoae, M. and Chitescu, C.L (2026) 'Efficacy and Safety of Herbal Supplements with Anxiolytic, Antidepressant, and Sedative Action: A Review of Clinical Data and Toxicological Risks', Pharmaceuticals, 19(3), pp. 399. doi:10.3390/ph19030399 Meta-analysis / review
https://doi.org/10.3390/ph19030399
- Bekara, A., Amazouz, A. and Douma, T.B (2020) 'Evaluating the Antidepressant Effect of Verbena officinalis L. (Vervain) Aqueous Extract in Adult Rats', Basic and Clinical Neuroscience, 11(1), pp. 91-98. doi:10.32598/bcn.11.1.3 Preclinical
https://doi.org/10.32598/bcn.11.1.3 - Rodrigues Oliveira, S.M., Dias, E., Girol, A.P., Silva, H. and others (2022) 'Exercise Training and Verbena officinalis L. Affect Pre-Clinical and Histological Parameters', Plants, 11(22), pp. 3115. doi:10.3390/plants11223115 Preclinical
https://doi.org/10.3390/plants11223115 - Dong, J., Du, C., Xu, C., Wang, Q. and others (2023) 'Verbenalin attenuates hepatic damage and mitochondrial dysfunction in alcohol-associated steatohepatitis by regulating MDMX/PPARalpha-mediated ferroptosis', Journal of Ethnopharmacology, 307, pp. 116227. doi:10.1016/j.jep.2023.116227 Preclinical
https://doi.org/10.1016/j.jep.2023.116227 - Nisar, R., Adhikary, S., Ahmad, S. and Alam, M.A (2022) 'In Vitro Antimelanoma Properties of Verbena officinalis Fractions', Molecules, 27(19), pp. 6329. doi:10.3390/molecules27196329 Preclinical
https://doi.org/10.3390/molecules27196329 - Dai, X., Zhou, X., Shao, R., Zhao, R. and others (2023) 'Bioactive Constituents of Verbena officinalis Alleviate Inflammation and Enhance Killing Efficiency of Natural Killer Cells', International Journal of Molecular Sciences, 24(8), pp. 7144. doi:10.3390/ijms24087144 Preclinical
https://doi.org/10.3390/ijms24087144 - Zhang, W., Zhang, P., Xu, L.H., Gao, K. and others (2023) 'Ethanol extract of Verbena officinalis alleviates MCAO-induced ischaemic stroke by inhibiting IL17A pathway-regulated neuroinflammation', Phytomedicine, 123, pp. 155237. doi:10.1016/j.phymed.2023.155237 Preclinical
https://doi.org/10.1016/j.phymed.2023.155237 - Kubica, P., Szopa, A. and Ekiert, H (2017) 'Production of verbascoside and phenolic acids in biomass of Verbena officinalis L. (vervain) cultured under different in vitro conditions', Natural Product Research, 31(14), pp. 1663-1668. doi:10.1080/14786419.2017.1286477 Preclinical
https://doi.org/10.1080/14786419.2017.1286477 - Yang, J.Y., Guo, C.S., Su, L., Xu, C.X. and others (2023) 'Four undescribed triterpenes from the aerial parts of Verbena officinalis', Fitoterapia, 170, pp. 105670. doi:10.1016/j.fitote.2023.105670 Preclinical
https://doi.org/10.1016/j.fitote.2023.105670 - Chen, Y., Gan, Y., Yu, J., Ye, X. and others (2023) 'Key ingredients in Verbena officinalis and determination of their anti-atherosclerotic effect using a computer-aided drug design approach', Frontiers in Plant Science, 14, pp. 1154266. doi:10.3389/fpls.2023.1154266 Preclinical
https://doi.org/10.3389/fpls.2023.1154266 - Peng, S., Li, F., Yu, K., Zhou, F. and others (2022) 'Integrating transcriptome and chemical analyses to reveal the anti-Alzheimer's disease components in Verbena officinalis Linn', Frontiers in Plant Science, 13, pp. 955075. doi:10.3389/fpls.2022.955075 Preclinical
https://doi.org/10.3389/fpls.2022.955075 - (2020) 'Verbena officinalis (Common Vervain) - A Review on the Investigations of This Medicinally Important Plant Species', Planta Medica. doi:10.1055/a-1232-5758 Traditional / reference
https://doi.org/10.1055/a-1232-5758 - Khan, A.W., Khan, A.U. and Ahmed, T (2016) 'Anticonvulsant, Anxiolytic, and Sedative Activities of Verbena officinalis', Frontiers in Pharmacology. doi:10.3389/fphar.2016.00499 Preclinical
https://doi.org/10.3389/fphar.2016.00499 - Ghasemzadeh Rahbardar, M. and Hosseinzadeh, H (2024) 'Therapeutic potential of hypnotic herbal medicines: A comprehensive review', Phytotherapy Research, 38(6), pp. 3037-3059. doi:10.1002/ptr.8201 Meta-analysis / review
https://doi.org/10.1002/ptr.8201 - Block, K.I., Gyllenhaal, C. and Mead, M.N (2004) 'Safety and efficacy of herbal sedatives in cancer care', Integrative Cancer Therapies, 3(2), pp. 128-148. doi:10.1177/1534735404265003 Meta-analysis / review
https://doi.org/10.1177/1534735404265003
Generated automatically from the Omnia Sana plant database and its cited sources. For educational purposes only — not medical advice. Always consult a qualified practitioner before using medicinal plants.